Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 190 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Adjuvant Dabrafenib and Trametinib Treatment in Patients With Completely Resected High-risk Stage III Melanoma.

Melanoma Turkey

A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia

Breast Cancer Russian Federation

Study of Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-positive Differentiated Thyroid Cancer

Differentiated Thyroid Cancer Phase 3 United States
Turkey
China
Brazil
Argentina
India
Mexico
Canada
Vietnam
Malaysia
Korea, Republic of
Taiwan
View All

Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent

Multiple Sclerosis United States

Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA)

Giant Cell Arteritis (GCA) Phase 3 United States
Portugal
Greece
Spain
Brazil
Czech Republic
Hungary
Poland
Argentina
Chile
Australia
United Kingdom
Guatemala
Israel
Sweden
Norway
Estonia
Austria
View All

Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis

Multiple Sclerosis (MS) Phase 3 United States
Spain
Serbia
Germany
Slovakia
Romania
Argentina
Mexico
Portugal
Brazil
Belgium
Poland
Guatemala
Turkey
Taiwan
India
France
Chile
United Kingdom
Italy
Canada
Australia
Israel
Latvia
Russian Federation
Estonia
Austria
Croatia
View All

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

Myeloid Leukemia, Philadelphia Positive Phase 1, Phase 2 United States
Greece
Thailand
China
France
Hungary
Turkey
Germany
Italy
Russian Federation
Japan
Korea, Republic of
Netherlands
Poland
View All

Study of VAY736 as Single Agent and in Combination With Select Antineoplastic Agents in Patients With Non-Hodgkin Lymphoma

Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma Phase 1 Italy
Germany
Spain
China
Korea, Republic of
Singapore
View All

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

Atypical Hemolytic Uremic Syndrome Phase 3 United States
Greece
China
Brazil
Slovakia
Japan
India
Austria
Slovenia
United Kingdom
Czech Republic
Korea, Republic of
Taiwan
View All

Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis

Symptomatic Knee Osteoarthritis Phase 2 United States
Spain
Germany
Czech Republic
Romania
Hungary
Argentina
Slovakia
View All